342 related articles for article (PubMed ID: 18982394)
1. Molecular staging of pathologically negative sentinel lymph nodes from melanoma patients using multimarker, quantitative real-time rt-PCR.
Hilari JM; Mangas C; Xi L; Paradelo C; Ferrándiz C; Hughes SJ; Yueh C; Altomare I; Gooding WE; Godfrey TE
Ann Surg Oncol; 2009 Jan; 16(1):177-85. PubMed ID: 18982394
[TBL] [Abstract][Full Text] [Related]
2. Molecular upstaging based on paraffin-embedded sentinel lymph nodes: ten-year follow-up confirms prognostic utility in melanoma patients.
Nicholl MB; Elashoff D; Takeuchi H; Morton DL; Hoon DS
Ann Surg; 2011 Jan; 253(1):116-22. PubMed ID: 21135695
[TBL] [Abstract][Full Text] [Related]
3. Multimarker reverse transcriptase-polymerase chain reaction assay in lymphatic drainage and sentinel node tumor burden.
Rutkowski P; Nowecki ZI; van Akkooi AC; Kulik J; Wanda M; Siedlecki JA; Eggermont AM; Ruka W
Ann Surg Oncol; 2010 Dec; 17(12):3314-23. PubMed ID: 20607422
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of molecular staging study of sentinel lymph nodes by reverse transcriptase-polymerase chain reaction for tyrosinase in melanoma patients.
Mangas C; Hilari JM; Paradelo C; Rex J; Fernández-Figueras MT; Fraile M; Alastrue A; Ferrándiz C
Ann Surg Oncol; 2006 Jul; 13(7):910-8. PubMed ID: 16788751
[TBL] [Abstract][Full Text] [Related]
5. Quantification of melanoma micrometastases in sentinel lymph nodes using real-time RT-PCR.
Giese T; Engstner M; Mansmann U; Hartschuh W; Arden B
J Invest Dermatol; 2005 Mar; 124(3):633-7. PubMed ID: 15737205
[TBL] [Abstract][Full Text] [Related]
6. Prospective multi-institutional study of reverse transcriptase polymerase chain reaction for molecular staging of melanoma.
Scoggins CR; Ross MI; Reintgen DS; Noyes RD; Goydos JS; Beitsch PD; Urist MM; Ariyan S; Davidson BS; Sussman JJ; Edwards MJ; Martin RC; Lewis AM; Stromberg AJ; Conrad AJ; Hagendoorn L; Albrecht J; McMasters KM
J Clin Oncol; 2006 Jun; 24(18):2849-57. PubMed ID: 16782924
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of molecular upstaging of paraffin-embedded sentinel lymph nodes in melanoma patients.
Takeuchi H; Morton DL; Kuo C; Turner RR; Elashoff D; Elashoff R; Taback B; Fujimoto A; Hoon DS
J Clin Oncol; 2004 Jul; 22(13):2671-80. PubMed ID: 15226334
[TBL] [Abstract][Full Text] [Related]
8. Molecular Staging of Sentinel Lymph Nodes Identifies Melanoma Patients at Increased Risk of Nodal Recurrence.
Kimbrough CW; Egger ME; McMasters KM; Stromberg AJ; Martin RC; Philips P; Scoggins CR
J Am Coll Surg; 2016 Apr; 222(4):357-63. PubMed ID: 26875070
[TBL] [Abstract][Full Text] [Related]
9. Highly sensitive multivariable assay detection of melanocytic differentiation antigens and angiogenesis biomarkers in sentinel lymph nodes with melanoma micrometastases.
Vitoux D; Mourah S; Kerob D; Verola O; Basset-Seguin N; Baccard M; Schartz N; Ollivaud L; Archimbaud A; Servant JM; Revol M; Toubert ME; Podgorniak MP; Plassa F; Porcher R; Lebbé C
Arch Dermatol; 2009 Oct; 145(10):1105-13. PubMed ID: 19841396
[TBL] [Abstract][Full Text] [Related]
10. Detection of tyrosinase mRNA by reverse transcription-polymerase chain reaction in melanoma sentinel nodes.
Bieligk SC; Ghossein R; Bhattacharya S; Coit DG
Ann Surg Oncol; 1999; 6(3):232-40. PubMed ID: 10340881
[TBL] [Abstract][Full Text] [Related]
11. Serial follow-up and the prognostic significance of reverse transcriptase-polymerase chain reaction--staged sentinel lymph nodes from melanoma patients.
Kammula US; Ghossein R; Bhattacharya S; Coit DG
J Clin Oncol; 2004 Oct; 22(19):3989-96. PubMed ID: 15459222
[TBL] [Abstract][Full Text] [Related]
12. Molecular staging of the sentinel lymph node in melanoma patients: correlation with clinical outcome.
Romanini A; Manca G; Pellegrino D; Murr R; Sarti S; Bianchi F; Alsharif A; Orlandini C; Zucchi V; Castagna M; Gandini D; Salimbeni G; Ghiara F; Barachini P; Mariani G
Ann Oncol; 2005 Nov; 16(11):1832-40. PubMed ID: 16107497
[TBL] [Abstract][Full Text] [Related]
13. Detection of melanoma cells in sentinel lymph nodes, bone marrow and peripheral blood by a reverse transcription-polymerase chain reaction assay in patients with primary cutaneous melanoma: association with Breslow's tumour thickness.
Blaheta HJ; Paul T; Sotlar K; Maczey E; Schittek B; Paul A; Moehrle M; Breuninger H; Bueltmann B; Rassner G; Garbe C
Br J Dermatol; 2001 Aug; 145(2):195-202. PubMed ID: 11531779
[TBL] [Abstract][Full Text] [Related]
14. Pathologic assessment of melanoma sentinel nodes: a role for molecular analysis using quantitative real-time reverse transcription-PCR for MART-1 and tyrosinase messenger RNA.
Abrahamsen HN; Sorensen BS; Nexo E; Hamilton-Dutoit SJ; Larsen J; Steiniche T
Clin Cancer Res; 2005 Feb; 11(4):1425-33. PubMed ID: 15746042
[TBL] [Abstract][Full Text] [Related]
15. Molecular and biochemical testing in stage III melanoma: multimarker reverse transcriptase-polymerase chain reaction assay of lymph fluid after lymph node dissection and preoperative serum lactate dehydrogenase level.
Nowecki ZI; Rutkowski P; Kulik J; Siedlecki JA; Ruka W
Br J Dermatol; 2008 Sep; 159(3):597-605. PubMed ID: 18616789
[TBL] [Abstract][Full Text] [Related]
16. Detection of micrometastasis in sentinel lymph nodes of patients with primary cutaneous melanoma.
Blaheta HJ; Schittek B; Breuninger H; Garbe C
Recent Results Cancer Res; 2001; 158():137-46. PubMed ID: 11092041
[TBL] [Abstract][Full Text] [Related]
17. [The sentinel lymph node in melanoma: utilization of molecular biology (RT-PCR) to detect occult metastases].
Riccioni L; Farabegoli P; Nanni O; Morigi F; Polverelli M; Landi G; Giangaspero F
Pathologica; 2002 Aug; 94(4):190-5. PubMed ID: 12325417
[TBL] [Abstract][Full Text] [Related]
18. Prediction of disease outcome in melanoma patients by molecular analysis of paraffin-embedded sentinel lymph nodes.
Kuo CT; Hoon DS; Takeuchi H; Turner R; Wang HJ; Morton DL; Taback B
J Clin Oncol; 2003 Oct; 21(19):3566-72. PubMed ID: 12913098
[TBL] [Abstract][Full Text] [Related]
19. Multimarker quantitative real-time PCR detection of circulating melanoma cells in peripheral blood: relation to disease stage in melanoma patients.
Koyanagi K; Kuo C; Nakagawa T; Mori T; Ueno H; Lorico AR; Wang HJ; Hseuh E; O'Day SJ; Hoon DS
Clin Chem; 2005 Jun; 51(6):981-8. PubMed ID: 15817820
[TBL] [Abstract][Full Text] [Related]
20. Molecular staging of malignant melanoma: correlation with clinical outcome.
Shivers SC; Wang X; Li W; Joseph E; Messina J; Glass LF; DeConti R; Cruse CW; Berman C; Fenske NA; Lyman GH; Reintgen DS
JAMA; 1998 Oct; 280(16):1410-5. PubMed ID: 9801000
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
